Clinical Trial Update: Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer [Phase 1]

View source ↗

Summary

A completed Phase I trial evaluated adjuvant therapy with gemcitabine or S-1 after hemihepatectomy in biliary tract cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Kansai Hepatobiliary Oncology Group | Conditions: Biliary Tract Cancer | Phase 1 | Status: COMPLETED